Verigene Gram Negative Blood Culture Nucleic Acid Test (Bc-Gn)

FDA 510(k) K132843 · Nanosphere, Inc.

Substantially Equivalent

510(k) numberK132843

Submission

Device name
Verigene Gram Negative Blood Culture Nucleic Acid Test (Bc-Gn)
Applicant
Nanosphere, Inc.
Northbrook, IL, US
Received
September 10, 2013
Decision date
January 8, 2014
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
PEN – Gram-Negative Bacteria And Associated Resistance Markers
Device class
Class II (moderate risk)
Regulation
21 CFR 866.3365
Specialty
Microbiology

A qualitative multiplexed in vitro diagnostic device to detect and identify gram-negative bacteria and resistance markers in positive blood cultures.

Other 510(k)s with product code PEN

510(k)DeviceApplicantDecision
K243013LIAISON PLEX Gram-Negative Blood Culture AssayPEN · Traditional Luminex Corporation04/18/2025SE
K243759BIOFIRE Blood Culture Identification 2 (BCID2) Panel (RFIT-ASY-0147 (30 pack)…PEN · Special Biofire Diagnostics, LLC12/20/2024SE
K213236ePlex Blood Culture Identification Gram Negative (BCID-GN) PanelPEN · Traditional Genmark Diagnostics, Incorporated04/27/2022SE
K193519BioFire Blood Culture Identification 2 (BCID2) PanelPEN · Traditional Biofire Diagnostics, LLC03/18/2020SE
K190341iC-GN iC-Cassette for use on the iC-SystemPEN · Traditional Icubate, Inc.06/28/2019SE
K182619ePlex Blood Culture Identification Gram Negative (BCID-GN) PanelPEN · Traditional Genmark Diagnostics, Incorporated04/12/2019SE
K181493FilmArray Blood Culture Identification (BCID) PanelPEN · Special Biofire Diagnostics, LLC07/05/2018SE
K160457FilmArray Blood Culture Identification (BCID) panel for use with FilmArray TorchPEN · Special Biofire Diagnostics, LLC03/15/2016SE
K143171FilmArray Blood Culture Identification (BCID) Panel for use with the FilmArray 2.0PEN · Traditional Biofire Diagnostics, LLC01/30/2015SE
K130914Filmarray Blood Culture Identification (Bcid) PanelPEN · Traditional Biofire Diagnostics, Inc.06/21/2013SE

More from Biofire Diagnostics, Inc.

510(k)DeviceDecision
K143653Verigene Respiratory Pathogens Flex Nucleic Acid Test (RP Flex)OCC · Traditional 09/04/2015SE
K140083Verigene Enteric Pathogen Nucleic Acid Test ( Ep)PCH · Traditional 06/20/2014SE
K123197Verigene C. Difficile Nucleic Acid Test (CDF)OZN · Traditional 12/05/2012SE
K120466Verigene CYP2C19 Nucleic Acid Tes (2C19)NTI · Traditional 11/06/2012SE
K122514Verigene Gram-Positive Blood Culture (Gc-Gp) Nucleic Acid TestPAM · Traditional 09/19/2012SE
K112424Verigene Staphylococcus Blood Culture Nucleic Acid Test (Bc-S)NQX · Traditional 12/16/2011SE
K103209Verigene Respiratory Virus Nucleic Acid Test +(Rvnat+)OCC · Traditional 01/10/2011SE
K093337Verigene Respiratory Virus Nucleic Acid Test on the Verigene SP SystemOCC · Special 11/17/2009SE
K092957Verigene System, Verigene Respiratory Virus Nucleic Acid TestOCC · Special 10/21/2009SE
K092566Verigene Respiratory Virus Nucleic Acid Test on the Verigene SP System (Rvnatsp)OCC · Traditional 10/09/2009SE

Questions and answers

When was Verigene Gram Negative Blood Culture Nucleic Acid Test (Bc-Gn) cleared by the FDA?

Verigene Gram Negative Blood Culture Nucleic Acid Test (Bc-Gn) (K132843) received a 510(k) decision of Substantially Equivalent on January 8, 2014, 120 days after the submission was received.

What is the product code of K132843?

The FDA product code is PEN – Gram-Negative Bacteria And Associated Resistance Markers, a Class II (moderate risk) device regulated under 21 CFR 866.3365.